{"id":8637,"date":"2021-01-26T00:00:00","date_gmt":"2021-01-26T00:00:00","guid":{"rendered":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2021\/01\/26\/hospitalizations-for-diabetic-foot-ulcer-up-in-australia\/"},"modified":"2021-01-27T18:10:27","modified_gmt":"2021-01-27T18:10:27","slug":"hospitalizations-for-diabetic-foot-ulcer-up-in-australia","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2021\/01\/26\/hospitalizations-for-diabetic-foot-ulcer-up-in-australia\/","title":{"rendered":"Hospitalizations for Diabetic Foot Ulcer Up in Australia"},"content":{"rendered":"<h3>\n<p>Risk factors include peripheral sensory neuropathy, peripheral arterial disease, nephropathy, and poor glycemic control<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, Jan. 26, 2021 (HealthDay News) &#8212; Hospitalizations for diabetes-related foot ulcers (DFUs) are increasing, according to a study published online Jan. 13 in <em>Diabetes Care<\/em>.<\/p>\n<p>Emma J. Hamilton, Ph.D., from the University of Western Australia in Perth, and colleagues used data from the Fremantle Diabetes Study phases I (FDS1; 1,296 participants, recruited 1993 to 1996) and II (FDS2; 1,509 participants, recruited 2008 to 2011). Participants were followed from entry to first hospitalization for or with DFU, death, or five years.<\/p>\n<p>The researchers found that incident DFU hospitalization was 1.9 per 1,000 person-years in FDS1 and 4.5 per 1,000 person-years in FDS2. The crude incident rate ratio was 2.40, and the incident rate difference was 2.6 per 1,000 person-years. FDS2 participants aged 31 to 40 years had the highest incident rate for any age group (23.6 per 1,000 person-years). Independent predictors of incident hospitalization for or with DFU included age at diabetes diagnosis (inverse), hemoglobin A1c, insulin use, height, ln(urinary albumin\/creatinine), absence of any foot pulse, previous peripheral revascularization, and peripheral sensory neuropathy (PSN).<\/p>\n<p>&#8220;Incident DFU hospitalizations complicating type 2 diabetes increased between FDS phases, especially in younger participants, and were more likely in those with PSN, peripheral arterial disease, and suboptimal glycemic control at baseline,&#8221; the authors write.<\/p>\n<p><a href=\"https:\/\/care.diabetesjournals.org\/content\/early\/2021\/01\/11\/dc20-1743\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Risk factors include peripheral sensory neuropathy, peripheral arterial disease, nephropathy, and poor glycemic control<\/p>\n","protected":false},"author":4,"featured_media":8830,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[85],"tags":[89,441,500],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/8637"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=8637"}],"version-history":[{"count":0,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/8637\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media\/8830"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=8637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=8637"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=8637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}